Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $3.02 billion. The enterprise value is $2.35 billion.

Market Cap	3.02B
Enterprise Value	2.35B

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

DYN has 142.82 million shares outstanding. The number of shares has increased by 39.30% in one year.

Current Share Class	142.82M
Shares Outstanding	142.82M
Shares Change (YoY)	+39.30%
Shares Change (QoQ)	+24.53%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	103.02%
Float	132.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.36
P/TBV Ratio	4.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.47, with a Debt / Equity ratio of 0.17.

Current Ratio	13.47
Quick Ratio	13.23
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-149.82

Financial Efficiency

Return on equity (ROE) is -60.66% and return on invested capital (ROIC) is -36.40%.

Return on Equity (ROE)	-60.66%
Return on Assets (ROA)	-34.32%
Return on Invested Capital (ROIC)	-36.40%
Return on Capital Employed (ROCE)	-55.64%
Revenue Per Employee	n/a
Profits Per Employee	-$2.22M
Employee Count	191
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.12% in the last 52 weeks. The beta is 1.30, so DYN's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-28.12%
50-Day Moving Average	17.41
200-Day Moving Average	12.91
Relative Strength Index (RSI)	57.63
Average Volume (20 Days)	2,594,634

Short Selling Information

The latest short interest is 17.11 million, so 11.98% of the outstanding shares have been sold short.

Short Interest	17.11M
Short Previous Month	15.12M
Short % of Shares Out	11.98%
Short % of Float	12.88%
Short Ratio (days to cover)	5.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-449.16M
Pretax Income	-423.80M
Net Income	-423.80M
EBITDA	-447.19M
EBIT	-449.16M
Earnings Per Share (EPS)	-$3.62

Balance Sheet

The company has $791.89 million in cash and $120.47 million in debt, giving a net cash position of $671.42 million or $4.70 per share.

Cash & Cash Equivalents	791.89M
Total Debt	120.47M
Net Cash	671.42M
Net Cash Per Share	$4.70
Equity (Book Value)	691.78M
Book Value Per Share	4.85
Working Capital	746.41M

Cash Flow

In the last 12 months, operating cash flow was -$375.71 million and capital expenditures -$21.30 million, giving a free cash flow of -$397.01 million.

Operating Cash Flow	-375.71M
Capital Expenditures	-21.30M
Free Cash Flow	-397.01M
FCF Per Share	-$2.78

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.30%
Shareholder Yield	n/a
Earnings Yield	-14.02%
FCF Yield	-13.13%

Analyst Forecast

The average price target for DYN is $36.53, which is 72.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.53
Price Target Difference	72.56%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1